Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]

BACKGROUND: Activation of inflammatory pathways plays an important contributory role in coronary plaque instability and subsequent rupture, which can lead to the development of acute coronary syndrome (ACS). Elevated levels of serum inflammatory markers such as C-reactive protein (CRP) represent ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostadal, Petr, Alan, David, Hajek, Petr, Vejvoda, Jiri, Mates, Martin, Blasko, Peter, Veselka, Josef, Kvapil, Milan, Kettner, Jiri, Wiendl, Martin, Aschermann, Ondrej, Slaby, Josef, Nemecek, Eduard, Holm, Frantisek, Rac, Marek, Macek, Milan, Cepova, Jana
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555952/
https://www.ncbi.nlm.nih.gov/pubmed/15790413
http://dx.doi.org/10.1186/1468-6708-6-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555952/
https://www.ncbi.nlm.nih.gov/pubmed/15790413
http://dx.doi.org/10.1186/1468-6708-6-4

Ejemplares similares